Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 4/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.40 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22444754 | 1.00 | TSHR (0.50) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL22444751 | 1.00 | TSHR (0.50) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL8517638 | 1.00 | TSHR (0.50) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL30714953 | 0.98 | TSHR (0.52) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL6690451 | 0.98 | TSHR (0.52) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL4981071 | 0.92 | TSHR (0.53) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL4738271 | 0.86 | TSHR (0.55) | TSHRPPARGGABRA1GABRB2ALDH1A1 | |
| SCHEMBL22444478 | 0.86 | TSHR (0.47) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL11809865 | 0.86 | TSHR (0.47) | TSHRPPARGGABRA1GABRB2CSNK1E | |
| SCHEMBL9790245 | 0.86 | MEN1 (0.44) | TSHRPPARGCSNK1EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113574041-A | Method for producing bisphenol and method for producing polycarbonate resin | 三菱化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| WO-2020189201-A1 | METHOD FOR PRODUCING BISPHENOL AND METHOD FOR PRODUCING POLYCARBONATE RESIN | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| US-20090227540-A1 | TREATMENT OF WOOD BASED ON NOVEL FORMULATIONS OF BORATRANES | TAPUAE PARTNERSHIP (NZ) | 2009-09-10 | — | — | US | disclosed |
| EP-1965958-A1 | TREATMENT OF WOOD BASED ON NOVEL FORMULATIONS OF BORATRANES | Tapuae Partnership (NZ) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007064236-A1 | TREATMENT OF WOOD BASED ON NOVEL FORMULATIONS OF BORATRANES | TAPUAE PARTNERSHIP (NZ) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227540-A1 | TREATMENT OF WOOD BASED ON NOVEL FORMULATIONS OF BORATRANES | BLVRB, BCHE, MGAM | TSHR 3334/4885PPARG 4614/4885GABRA1 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.